Recall Notice

Product recalls are not formally tracked. When the FDA issues a recall or a manufacturer sends a notice, it arrives by email or fax and may or may not reach the right person. Nobody systematically checks whether affected products are in inventory or have been used on patients. Recall response depends on whether the right staff member happens to see the notification.

None — AI cannot manage recall compliance, identify affected inventory, or trace implanted products because no formal recall notice tracking exists.

Recall notices are logged when received, but documentation is inconsistent. Some notices are fully documented with affected lot numbers and required actions; others are filed with only the vendor name and a general description. The recall log exists but is not reliable as a comprehensive record of all affected products and required responses.

AI can list logged recalls, but cannot determine which specific inventory lots are affected or verify that all required actions have been completed because the notice documentation lacks the specificity needed for systematic response.

Recall notices follow standardized documentation with FDA recall class, affected products with item master cross-references, affected lot number ranges, risk descriptions, required actions for inventory and patient notification, response deadlines, and assigned responsible parties. The quality team can systematically track every recall from notification through resolution. But recall records are standalone — they are not linked to actual inventory positions or patient implant records.

AI can manage recall workflows, track response deadlines, and monitor completion status. Cannot identify whether affected lots are in inventory or have been used on patients because recall records are not connected to inventory tracking or patient records.

Recall notices connect to inventory and patient context. Each recall links to specific inventory positions containing affected lots (with quantities and locations) and to patient records where affected products were used (implant registries, supply charge records). The quality team can immediately answer 'which patients received products from recalled lot X and where is remaining recalled inventory located?'

AI can perform immediate recall impact assessment — quantifying affected inventory by location, identifying patients who received recalled products, and generating both inventory quarantine and patient notification action plans from linked records.

Recall notices are schema-driven entities with full relational modeling. Each recall links to FDA classification records, affected product catalogs with item master cross-references, inventory lot positions by location, patient exposure records from implant registries and charge records, response action plans with completion tracking, and regulatory submission records. An AI agent can navigate the complete recall impact from notification through response.

AI can autonomously manage recall response — identifying affected inventory, generating quarantine orders, producing patient notification lists, tracking action plan completion, and preparing regulatory response documentation through the complete recall entity graph.

Recall management is a real-time intelligence capability. FDA notifications arrive through automated feeds and immediately trigger impact assessment, inventory quarantine, and patient identification. Every response action is tracked in real-time. Recall management is not a reactive process but a continuously operating safety system that responds to product safety signals as they emerge.

Fully autonomous recall management intelligence — detecting recalls in real-time, assessing impact across inventory and patient populations, executing response protocols, and managing regulatory compliance as a continuous safety engine.

Ceiling of the CMC framework for this dimension.